PMID: 26838254Feb 4, 2016Paper

Reversal of Multidrug Resistance in Mouse Lymphoma Cells by Extracts and Flavonoids from Pistacia integerrima

Asian Pacific Journal of Cancer Prevention : APJCP
Abdur RaufDiana Szabó

Abstract

Phytochemical investigation of Pistacia integerrima has highlighted isolation of two known compounds naringenin (1) and dihydrokaempferol (2). A crude extract and these isolated compounds were here evaluated for their effects on reversion of multidrug resistance (MDR) mediated by P-glycoprotein (P-gp). The multidrug resistance P-glycoprotein is a target for chemotherapeutic drugs from cancer cells. In the present study rhodamine- 123 exclusion screening test on human mdr1 gene transfected mouse gene transfected L5178 and L5178Y mouse T-cell lymphoma cells showed excellent MDR reversing effects in a dose dependent manner. In-silico molecular docking investigations demonstrated a common binding site for Rhodamine123, and compounds naringenin and dihydrokaempferol. Our results showed that the relative docking energies estimated by docking softwares were in satisfactory correlation with the experimental activities. Preliminary interaction profile of P-gp docked complexes were also analysed in order to understand the nature of binding modes of these compounds. Our computational investigation suggested that the compounds interactions with the hydrophobic pocket of P-gp are mainly related to the inhibitory activity. Moreover this stud...Continue Reading

References

Feb 1, 1995·Protein Engineering·A C WallaceJ M Thornton
Feb 1, 1993·Seminars in Cell Biology·U A GermannM M Gottesman
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·L A DoyleD D Ross
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Jan 24, 2002·Journal of Bioenergetics and Biomembranes·M M Gottesman, S V Ambudkar
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Jul 18, 2002·Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology·Mariël BrinkhuisRik J Scheper
Oct 8, 2003·The Oncologist·Gregory D LeonardSusan E Bates
Mar 31, 2004·Cellular and Molecular Life Sciences : CMLS·P M Jones, A M George
Sep 8, 2004·International Journal of Cancer. Journal International Du Cancer·Annemarie LarkinMartin Clynes
Sep 28, 2004·Journal of Chemical Information and Computer Sciences·Zhenjiang LiPingkai Ouyang
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Jul 6, 2006·Trends in Pharmacological Sciences·Susan P C Cole, Roger G Deeley
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Yehuda G Assaraf
Feb 27, 2007·Cancer Metastasis Reviews·Robert W RobeySusan E Bates
Mar 24, 2007·Pharmaceutical Research·Sébastien BihorelJean-Michel Scherrmann
Jan 22, 2010·Current Medicinal Chemistry·Y LiX Li
Apr 3, 2010·Journal of Ethnopharmacology·Naseem Saud AhmadAisha Qayyum
Aug 20, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Ghias Uddin Samiullah
Aug 15, 2012·Journal of Cheminformatics·Marcus D HanwellGeoffrey R Hutchison
Oct 2, 2012·Fitoterapia·Ghias UddinInamullah Khan
Oct 8, 2013·Journal of Molecular Graphics & Modelling·Gabriel E JaraAdriana B Pierini
Jan 24, 2014·Marine Drugs·Dioxelis Lopez, Sergio Martinez-Luis

❮ Previous
Next ❯

Citations

Aug 15, 2018·Toxicology Mechanisms and Methods·Amr A FouadManal I Abdelghany
Jun 28, 2019·Frontiers in Oncology·Qingmei YeRen-Wang Jiang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.